Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: A 16-week, randomized, double-blind, active control trial
- W. Yang
- , L. Chen
- , Q. Ji
- , X. Liu
- , J. Ma
- , N. Tandon
- , A. Bhattacharyya
- , A. Kumar
- , K. Kim
- , K. Yoon
- , O. M. Bech
- , M. Zychma
- China-Japan Friendship Hospital
- Wuhan Union Hospital
- Air Force Medical University
- the First Affiliated Hospital of Harbin Medical University
- Nanjing First Hospital
- All India Institute of Medical Sciences, New Delhi
- Manipal Academy of Higher Education
- Diabetes Care and Research Center
- Sungkyunkwan University
- Novo Nordisk Foundation
Research output: Contribution to journal › Article › peer-review
82
Scopus
citations